Teva's Plan B One-Step Trips As Watson's Generic Gains Market Share
This article was originally published in The Tan Sheet
Executive Summary
Sales ofPlan B One-Step are taking a substantial hit from generic levonorgestrel despite the product's single-dose formulation and Teva Pharmaceutical Industries' aggressive marketing
You may also be interested in...
Teva's Plan B One-Step OTC Application Puts FDA On The Spot
Teva Pharmaceutical Industries asks FDA to allow over-the-counter sales of Plan B One-Step, starting the likely final leg of the emergency contraceptive's journey toward OTC status.
In Brief
N.Y. rep to intro children's dosing bill
Plan B One-Step Boosts Teva's Women's Health Business
After a rocky launch, sales of Teva Pharmaceuticals' Plan B One-Step (levonorgestrel 1.5 mg) grew 55% in the firm's fiscal 2010 third quarter, Teva said Nov. 2.